Cellular Origins Launches Constellation, Its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell and gene therapies (CGTs), has today announced the launch of Constellation™, its closed, configurable,...